• IVV ETF and other iShares funds are paying dividends today. Here’s how much

    A businesman's hands surround a circular graphic with a United States flag and dollar signs, indicating buying and selling US shares

    BlackRock will pay dividends to investors who own iShares ASX exchange-traded funds (ETFs) today.

    The iShares funds paying out today are all invested in international shares or bonds.

    Among them is the mega-popular iShares S&P 500 ETF (ASX: IVV), which tracks the US benchmark S&P 500 Index (SP: INX).

    Aussie investors have enthusiastically invested in IVV ETF amid the US market’s outperformance over the past three years.

    US stocks have simply smashed the S&P/ASX 200 Index (ASX: XJO) for capital growth.

    In 2025, the S&P 500 rose by more than 16% while ASX 200 shares increased about 7%.

    In 2024, the S&P 500 rocketed about 25% while the ASX 200 lifted about 9%.

    In 2023, US stocks ripped 24% higher while ASX 200 shares climbed 8%.

    Here’s how much you will get today

    Here is a list of the final distribution amounts that iShares ETF investors will receive by close of business today.

    ASX ETF Distribution
    iShares S&P 500 ETF (ASX: IVV) 17.33 cents per unit
    iShares S&P Mid-Cap ETF (ASX: IJH) 12.94 cents per unit
    iShares S&P Small-Cap ETF (ASX: IJR) 59.66 cents per unit
    iShares U.S. Factor Rotation Active ETF (ASX: IACT) 2.42 cents per unit
    iShares Nasdaq Top 30 ETF (ASX: ITEK) 1.16 cents per unit
    iShares Core Global Corporate Bond (AUD Hedged) ETF (ASX: IHCB) 194.74 cents per unit
    iShares Global High Yield Bond (AUD Hedged) ETF (ASX: IHHY) 133.29 cents per unit
    iShares J.P. Morgan USD Emerging Markets Bond (AUD Hedged) ETF (ASX: IHEB) 72.68 cents per unit
    iShares Global Aggregate Bond ESG (AUD Hedged) ETF (ASX: AESG) 146.70 cents per unit
    iShares Core Global Aggregate Bond (AUD Hedged) ETF (ASX: AGGG) 67.70 cents per unit
    iShares U.S. Treasury Bond (AUD Hedged) ETF (ASX: IUSG) 201.61 cents per unit
    iShares World Equity High Income Complex ETF (ASX: WYNC) 70.28 cents per unit

    What about other ASX ETF dividends?

    Vanguard will pay its ASX ETF investors next Friday, 16 October.

    Find out how much you’ll get if you own Vanguard Australian Shares Index ETF (ASX: VAS), Vanguard MSCI Index International Shares ETF (ASX: VGS), or other Vanguard ETFs.

    Betashares will also pay its ETF investors next Friday.

    Find out how much you will receive if you’re invested in Betashares Australia 200 ETF (ASX: A200), Betashares Diversified All Growth ETF (ASX: DHHF), or other Betashares ETFs.

    VanEck is targeting next Friday for its dividend payments.

    Here’s how much you’ll get if you’re invested in VanEck 5-10 Year Australian Government Bond ETF (ASX: 5GOV) or other ETFs.

    Global X will pay dividends to investors on Monday, 19 October.

    Find out how much you’ll get if you own Global X Australia 300 ETF (ASX: A300), Global X S&P/ASX 200 High Dividend ETF (ASX: ZYAU), or other ETFs in the stable.

    The post IVV ETF and other iShares funds are paying dividends today. Here’s how much appeared first on The Motley Fool Australia.

    Should you invest $1,000 in iShares S&P 500 ETF right now?

    Before you buy iShares S&P 500 ETF shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and iShares S&P 500 ETF wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bronwyn Allen has positions in Vanguard Msci Index International Shares ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended iShares S&P 500 ETF. The Motley Fool Australia has recommended Vanguard Msci Index International Shares ETF and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 2 ASX 200 shares tipped to rise 39% to 130%

    Happy investor on tablet with finance graphs rising in overlay.

    If you are on the hunt for some big returns for your portfolio, then it could be worth looking at the two ASX 200 shares in this article.

    That’s because analysts are tipping them to rise between 39% and 130% over the next 12 months.

    Here’s what they are recommending:

    Megaport Ltd (ASX: MP1)

    The team at Morgans is positive on this cloud infrastructure company and believes it could be an ASX 200 share to snap up.

    In response to recent updates, the broker has lifted its earnings estimates and valuation accordingly.

    This has seen Morgans retain its buy rating with a new price target of $27.00. Based on its current share price of $19.38, this implies potential upside of 39% for investors.

    Commenting on the company, Morgans said:

    MP1 recently raised its FY27 EBITDA guidance by 25%. The compute and network businesses continue to deliver above expectations and MP1 announced three new AI infrastructure contracts with a Total Contract Value of ~A$1bn. Collectively these set a glide path for annualised EBITDA in excess of $850m. We upgrade our EPS forecasts materially. Our Target Price lifts to A$27 per share and we retain our BUY recommendation.

    Mesoblast Ltd (ASX: MSB)

    Another ASX 200 share that could rise materially according to analysts is biotechnology stock Mesoblast. 

    Bell Potter is positive on the company and sees significant value in its shares at current levels.

    This morning, it has retained its buy rating and $4.45 price target on Mesoblast shares. Based on its current share price of $1.94, this implies potential upside of approximately 130%.

    The broker highlights that there are a number of important events on the horizon. 

    The short term outlook for Mesoblast’s revenue growth remains highly attractive. Pivotal events for valuation are approaching, including the interim readout on the adult GvHD study (1QCY27) and the headline data from the chronic lower back pain trial (CLBP) due mid CY27. Both are substantially larger markets than paediatric GvHD, nevertheless the market remains cautious.

    Bell Potter then adds:

    MSB remains an enigma for most Australian long only institutions, despite having achieved multiple clinical trial successes, product approvals and revenues likely to exceed US$200m in FY27. We expect this information gap will close over the coming year as the company delivers on additional wins in the clinic. To this end, Dr Doug Beall is a leading investigator and KOL in the CLBP trial for Rexlemestrocel and is expected to present at the upcoming AGM. We maintain our buy rating and PT $4.45.

    The post 2 ASX 200 shares tipped to rise 39% to 130% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Megaport right now?

    Before you buy Megaport shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Megaport wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in Megaport. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Is the Fortescue share price a bargain buy?

    Business people discussing project on digital tablet.

    The Fortescue Ltd (ASX: FMG) share price has been having a tough year.

    The iron ore giant’s shares hit a new 52-week low this week following the release of a disappointing quarterly performance update.

    So, with the company’s shares down almost 30% since the start of the year, are they not a bargain buy?

    Is the Fortescue share price a bargain buy?

    Unfortunately, a couple of Australia’s leading brokers don’t believe that now is the time to buy shares.

    For example, a note out of Morgans reveals that its analysts have downgraded the miner’s shares to a trim rating with a reduced price target of $15.40 (from $18.70).

    Based on the current Fortescue share price of $15.79, this implies potential downside of 2.5% for investors. 

    Commenting on the quarterly update and downgrade, Morgans said:

    We have long argued that investing material capital in near-term loss-making projects (magnetite and new energy) has not diversified Fortescue, and has instead left group earnings more exposed to the iron ore price. Magnetite adds more iron ore exposure but at a higher cost, while new energy investment, and US$0.9-1.3bn of FY27 decarbonisation spend, are funded from hematite cash flow. This dynamic is starting to show in the numbers. 

    Fortescue flagged that net debt rose US$1.9bn in 1Q27, equal to the final dividend (US$1.0bn) plus quarterly capex (US$0.9bn), implying negative FCF for the quarter. We attribute this mainly to weaker hematite cash flow after the central buying group China Mineral Resources Group (CMRG) reportedly halted purchases of two of Fortescue’s products during the quarter, leaving shipments 6% and actual sales 14% below Visible Alpha (VA) consensus in 1Q27. On updated estimates we lower our rating to TRIM (from HOLD) with an A$15.40 target price (was A$18.70).

    Bell Potter says hold

    A note out of Bell Potter reveals that its analysts are a little more positive.

    According to the note, the broker has responded to the update by retaining its hold rating with a reduced price target of $15.80 (from $17.10). This is broadly in line with the current Fortescue share price.

    Speaking about the update, Bell Potter said:

    FMG has reported a suite of negative metrics in an out-of-cycle preliminary report updating performance for the September 2026 quarter. Total shipments were down 6% YoY to 46.8Mt (incl. 2.5Mt from Iron Bridge), with a scheduled port shutdown impacting volumes. Sales of 42.9Mt were 8% below shipments of 46.8Mt, with the 3.9Mt gap attributed to ongoing negotiations with China Mineral Resource Group (CMRG), China’s centralised ore buying agency. This is the first time FMG has disclosed a material discrepancy between shipments and sales. Price realisations also weakened to 82% (vs benchmark Platts 61%: US$80/dmt).

    We had previously flagged risks to price realisations and we now make a greater allowance and for longer through our forecast period. EPS changes in this report are: FY27 -6%, FY28 -6% and FY29 -7%. We lower our NPV-based target price by 8%, to $15.80/sh and retain our Hold recommendation.

    The post Is the Fortescue share price a bargain buy? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Fortescue right now?

    Before you buy Fortescue shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Fortescue wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Sorry, but nothing was found. Please try a search with different keywords.